Vivimed Labs to acquire European companyIllustrative image – not actual.

Hyderabad based Vivimed Labs, a specialty chemical and home and personal care company, is likely to acquire a Europe based company.

The proposed acquisition is valued at about $50 million (approx Rs 225 crore). The deal is likely to be finalised shortly. However, Vivimed has not disclosed the name of the target company. The identified company is engaged both in specialty chemicals and pharmaceuticals, according to sources.

The acquisition is likely utilise the proceeds from the to-be issued preferential issue for an amount up to $25 million (approx Rs 112.5 crore) for the proposed acquisition. The remaining funds are to come through internal accruals and debt.

← All latest storiesBack to top →